Travel-related dengue virus infection, the Netherlands, 2006-2007

Emerging Infectious Diseases

Volumn 17, Issue 5, 2011, Pages 821-828

  Baaten, Gijs G G ^a,b,c   Sonder, Gerard J B ^a,b,c   Zaaijer, Hans L ^a,b   van Gool, Tom ^a,b   Kint, Joan A P C M ^a   van den Hoek, Anneke ^a,b  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c National Coordination Center for Travelers Health Advice   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLTOLUAMIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INSECT REPELLENT;

ADULT; ARTHRALGIA; ARTICLE; BED NET; BLOOD SAMPLING; DENGUE; DENGUE LIKE ILLNESS; DEVELOPING COUNTRY; DIARRHEA; ENDEMIC DISEASE; FEMALE; FEVER; HEADACHE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYALGIA; NETHERLANDS; PAIN; PROSPECTIVE STUDY; RASH; RETROORBITAL PAIN; RISK FACTOR; SEASON; SEROCONVERSION; SEX DIFFERENCE; SYMPTOM; TRAVEL; VACCINATION; YELLOW FEVER;

ADULT; ANTIBODIES, VIRAL; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEROLOGIC TESTS; TRAVEL;

EID: 79955783166     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1705.101125     Document Type: Article

References (33)

1. Gibbons RV, Vaughn DW. Dengue: an escalating problem. BMJ. 2002;324:1563-6. doi:10.1136/bmj.324.7353.1563
2. World Health Organization. Report of the meeting of the Scientific Working Group on Dengue. Geneva: The Organization: 2006. p. 1-168 [cited 2010 Jun 17]. http://apps.who.int/tdr/svc/publications/tdr-research-publications/swg-report-dengue
3. Wichmann O, Gascon J, Schunk M, Puente S, Siikamaki H, Gjørup I, et al. European Network on Surveillance of Imported Infectious Diseases. Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis. 2007;195:1089-1096. doi:10.1086/512680
4. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: The Organization; 1997.
5. Wichmann O, Muehlberger N, Jelinek T. Dengue-the underestimated risk in travellers. Dengue Bull. 2003;27:126-37.
6. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181:2-9. doi:10.1086/315215
7. Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res. 2002;33:330-42. doi:10.1016/S0188-4409(02)00378-8
8. Jelinek T. Trends in the epidemiology of dengue fever and their relevance for importation to Europe. Euro Surveill. 2009; 14:pii:19250.
9. Wilson ME, Weld LH, Boggild A, Keystone JS, Kain KC, von Sonnenburg F, et al. GeoSentinel Surveillance Network. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis. 2007;44:1560-1568. doi:10.1086/518173
10. Cobelens FG, Groen J, Osterhaus AD, Leentvaar-Kuipers A, Wertheim- van Dillen PM, Kager PA. Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health. 2002;7:331-338. doi:10.1046/j.1365-3156.2002.00864.x
11. Potasman I, Srugo I, Schwartz E. Dengue seroconversion among Israeli travelers to tropical countries. Emerg Infect Dis. 1999;5:824-827. doi:10.3201/eid0506.990615
12. Schwartz E, Weld LH, Wilder-Smith A, von Sonnenburg F, Keystone JS, Kain KC, et al. GeoSentinel Surveillance Network. Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006. Emerg Infect Dis. 2008;14:1081-1088. doi:10.3201/eid1407.071412
13. Schwartz E, Moskovitz A, Potasman I, Peri G, Grossman Z, Alkan ML. Changing epidemiology of dengue fever in travelers to Thailand. Eur J Clin Microbiol Infect Dis. 2000;19:784-786. doi:10.1007/ s100960000388
14. Informatics GIDEON. The Global Infectious Diseases and Epidemiology Online Network. 1994-2009 [cited 2009 Sep 29]. http://web.gideononline.com/web/epidemiology/
15. Landelijk coördinatiecentrum reizigersadvisering. National Coordination Centre for Travelers' Health Advice. National guidelines for travelers' health advice. Amsterdam: Landelijk coördinatiecentrum reizigersadvisering; 2006.
16. United Nations Economic and Social Development Agency. Definition of major areas and regions [cited 2009 Aug 6]. http://esa.un.org/ unpp/definition.html
17. Groen J, Koraka P, Velzing J, Copra C, Osterhaus AD. Evaluation of six immunoassays for detection of dengue virus-specifi c immunoglobulin M and G antibodies. Clin Diagn Lab Immunol. 2000;7:867-71.
18. Lam SK, Devine PL. Evaluation of capture ELISA and rapid immunochromatographic test for the determination of IgM and IgG antibodies produced during dengue infection. Clin Diagn Virol. 1998;10:75-81. doi:10.1016/S0928-0197(98)00002-6
19. Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Nguyen MD, Kneen R, et al. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg. 1999;60:693-698.
20. McBride WJ, Mullner H, LaBrooy JT, Wronski I. The 1993 dengue 2 epidemic in North Queensland: a serosurvey and comparison of hemagglutination inhibition with an ELISA. Am J Trop Med Hyg. 1998;59:457-4561.
21. Balmaseda A, Saborio S, Tellez Y, Mercado JC, Pérez L, Hammond SN, et al. Evaluation of immunological markers in serum, fi lter-paper blood spots, and saliva for dengue diagnosis and epidemiological studies. J Clin Virol. 2008;43:287-291. doi:10.1016/j. jcv.2008.07.016
22. World Meteorological Organisation. World Weather Information Service [cited 2010 Jun 8]. http://www.worldweather.org/
23. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, et al. GeoSentinel Surveillance Network. Spectrum of disease and relation to place of exposure among ill returned travelers. [Erratum in: N Engl J Med. 2006;355: 967]. N Engl J Med. 2006;354:119-130. doi:10.1056/NEJMoa051331
24. Wilder-Smith A, Schwartz E. Dengue in travelers. N Engl J Med. 2005;353:924-932. doi:10.1056/NEJMra041927
25. Mohammed HP, Ramos MM, Rivera A, Johansson M, Munoz- Jordan JL, Sun W, et al. Travel-associated dengue infections in the United States, 1996 to 2005. J Travel Med. 2010;17:8-14. doi:10.1111/j.1708-8305.2009.00374.x
26. Leder K, Wilson ME, Freedman DO, Torresi J. A comparative analysis of methodological approaches used for estimating risk in travel medicine. J Travel Med. 2008;15:263-272. doi:10.1111/j.1708-8305.2008.00218.x
27. Franco L, Di Caro A, Carletti F, Vapalahti O, Renaudat C, Zeller H, et al. Recent expansion of dengue virus serotype 3 in west Africa. Euro Surveill. 2010;15:pii: 19490.
28. World Health Organization. Outbreak news. Chikungunya and dengue, south-west Indian Ocean. Wkly Epidemiol Rec. 2006;81: 106-8.
29. Van Herck K, Van Damme P, Castelli F, Zuckerman J, Nothdurft H, Dahlgren AL, et al. Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey. J Travel Med. 2004;11:3-8. doi:10.2310/7060.2004.13609
30. Massad E, Wilder-Smith A. Risk estimates of dengue in travelers to dengue endemic areas using mathematical models. J Travel Med. 2009;16:191-3. doi:10.1111/j.1708-8305.2009.00310.x
31. Schwartz E, Mileguir F, Grossman Z, Mendelson E. Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers. J Clin Virol. 2000;19:169-73. doi:10.1016/S1386-6532(00)00114-1
32. Roehrig JT, Hombach J, Barrett AD. Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Viral Immunol. 2008;21:123-132. doi:10.1089/vim.2008.0007
33. Lanciotti RS. Molecular amplifi cation assays for the detection of fl aviviruses. Adv Virus Res. 2003;61:67-99. doi:10.1016/S0065- 3527(03)61002-X